Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Patients With Inoperable Stage III and Stage IV Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Trametinib With GSK2141795 in BRAF Wild-type Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer
- Status
- COMPLETED
- Phase
- PHASE1
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
- Status
- COMPLETED
- Phase
- N/A
Tissue Procurement Substudy for Participants in Study CP-MGA271-01
- Status
- TERMINATED
- Phase
- PHASE1
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
- Status
- COMPLETED
- Phase
- PHASE1
Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
- Status
- COMPLETED
- Phase
- NA
BRAF Inhibitor, LGX818, Utilizing a Pulsatile Schedule in Patients With Stage IV or Unresectable Stage III Melanoma Characterized by a BRAFV600 Mutation
- Status
- COMPLETED
- Phase
- PHASE2
A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy Study of DCVax-Direct in Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Treatment of a Resistant Disease Using Decitabine Combined With Vemurafenib Plus Cobimetinib
- Status
- TERMINATED
- Phase
- PHASE1
Study to Evaluate the Safety and Efficacy of Two Different Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Participants With Advanced Melanoma (MK-3475-006/KEYNOTE-006)
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Melanoma Simulation Model With Smartphone Devices: Training Physicians for Early Detection of Melanoma
- Status
- COMPLETED
- Phase
- NA
Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Evaluation of a Multi-phosphopeptide Vaccine Plus PolyICLC in Participants With High Risk and Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1